Products and services using Biomaterials are generally available around 2017
Grader A: hit
Grader B: hit
agrees with A, without seeing its verdict
Audit: confirmed
in the fixed audit sample (D11)
Published: hit
Grader A: hit
The poster itself says biomaterials are already used; drug-eluting stents with polymer coatings for extended drug release were FDA approved in 2003 and made up 90% of stent implants by 2005.
Test: D37 Horizons: biomaterial medical products available to ordinary patients by 2019 (earlier counts).
Grader B: hit
Biomaterials were routine before 2014: drug-eluting stents with polymer release, resorbable sutures, collagen grafts and bone substitutes; the poster itself says 'already used'.
Test: Biomaterial products could be bought by clinicians/patients by 2019 (earlier counts).